| __timestamp | Taro Pharmaceutical Industries Ltd. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 55430000 | 242549000 |
| Thursday, January 1, 2015 | 65510000 | 245098000 |
| Friday, January 1, 2016 | 71160000 | 147600000 |
| Sunday, January 1, 2017 | 70644000 | 264600000 |
| Monday, January 1, 2018 | 70418000 | 357900000 |
| Tuesday, January 1, 2019 | 63238000 | 1182600000 |
| Wednesday, January 1, 2020 | 59777000 | 357700000 |
| Friday, January 1, 2021 | 60152000 | 540100000 |
| Saturday, January 1, 2022 | 54540000 | 322900000 |
| Sunday, January 1, 2023 | 52243000 | 408000000 |
| Monday, January 1, 2024 | 64536000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, United Therapeutics Corporation and Taro Pharmaceutical Industries Ltd. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, United Therapeutics consistently allocated a significant portion of its resources to R&D, peaking in 2019 with a staggering 1.18 billion dollars. This represents a nearly fivefold increase compared to Taro's highest expenditure in 2016. Meanwhile, Taro's R&D spending remained relatively stable, with a slight dip in 2023 to approximately 52 million dollars. This strategic difference highlights United Therapeutics' aggressive pursuit of innovation, while Taro maintains a more conservative approach. Notably, data for United Therapeutics in 2024 is missing, leaving room for speculation on future trends. As these companies navigate the ever-evolving pharmaceutical landscape, their R&D investments will undoubtedly shape their competitive edge.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Amgen Inc. vs Taro Pharmaceutical Industries Ltd.
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: United Therapeutics Corporation and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
R&D Insights: How CymaBay Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds